논문실적

Home › 연구실적 › 논문실적

총 410건
  1. 80
    Fluoxetine augmentation of haloperidol in chronic schizophrenia

    Shim JC, Kelly DL, Kim YH, Yoon YR, Park JH, Shin JG, Conley RR. · J Clin Psychopharmacol, 2003, 23/520~521 · 2003-International

  2. 79
    FACT Facilitates Transcription-Dependent Nucleosome Alteration

    Oh S, Belotserkovskaya R, Bondarenko VA, Orphanides G, Studitsky VM, Reinberg D. · Science, 2003, 301/1090~1093 · 2003-International

  3. 78
  4. 77
    Digoxin uptake, receptor heterogeneity and inotropic response in the isolated rat heart: A comprehensive kinetic model

    Kang W, Weiss M. · J Pharmacol Exp Ther, 2002, 302/755~583 · 2002-International

  5. 76
    P-glycoprotein inhibitors enhance saturable uptake of idarubicin in rat heart Pharmacokinetic/pharmacodynamic modeling

    Weiss M, Kang W. · J Pharmacol Exp Ther, 2002, 300/688~694 · 2002-International

  6. 75
    Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans

    Woo SK, Kang WK, Kwon KI. · Clin Pharmacol Ther, 2002, 71/246~252 · 2002-International

  7. 74
    Inhibitory effects of tricyclicantidepresants (TCAs) on human cytochrome P450 enzymes in vitro : Mechanism of drug interaction between TCAs and phenytoin

    Shin JG, Park JY, Kim MJ, Shon JH, Yoon YR, Cha IJ, Lee SS, Oh SW, Kim SW, Flockhart DA. · Drug Metab Dispos, 2002, 30/1102~1107 · 2002-International

  8. 73
    Association Between CYP2D6 Genotype and Tardive Kyskinesia in Korean Schizophrenics

    Nikoloff D, Shim JC, Fairchild M, Patten N, Fijal BA, Koch WH, MacPherson A, Flockhart D, Yoon YR, Yoon JS, Kim YH, Shin JG. · The Pharmacogenomics J, 2002, 2/400~407 · 2002-International

  9. 72
    Effect of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans

    Shon JH, Yoon YR, Kim KA, Lim YC, Lee KJ, Park JY, Cha IJ, Flockhart DA, Shin JG. · Pharmacogenetics, 2002, 12/111~119 · 2002-International

  10. 71
    Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19

    Kim KA, Shon JH, Park JY, Yoon YR, Kim MJ, Yun DH, Kim MK, Cha IJ, Hyun MH, Shin JG. · Clin Pharmacol Ther, 2002, 9/72~90 · 2002-International

  11. 70
    Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

    Desta Z, Zhao X, Shin JG, Flockhart DA. · Clin Pharmacokinet, 2002, 41/913~958 · 2002-International

  12. 69
    Dermal pharmacokinetics of the insecticide furathiocarb in Sprague-Dawley rats

    Liu KH, Sung HJ, Lee HK, Song BH, Ihm YB, Kim K, Lee HS, Kim JH. · Pest Manag Sci, 2002, 58/57~62 · 2002-International

  13. 68
    Structural Investigation of Pyribenzoxim Using X-ray Crystallography

    Liu KH, Rhee SK, Kim JH. · Bull Kor Chem Soc, 2002, 23/1042~1044 · 2002-Domestic

  14. 67
    Dissipation of foliar residues of diafenthiuron and its metabolites

    Keum YS, Liu KH, Seo JS, Kim JH, Kim K, Kim YH, Kim PJ. · Bull Environ Contam Toxicol, 2002, 68/845~821 · 2002-International

  15. 66
    Bioconcentration and depuration of pyribenzoxim in common carp (Cyprinus carpio)

    Seo JS, Liu KH, Chung KH, Shin JS, Kim JH. · Bull Environ Contam Toxicol, 2002, 68/617~622 · 2002-International